FindTrial
Sign In

Establishment of prospective clinical study cohort and biobank of Lupus Nephritis

Establishment of prospective clinical study cohort and biobank of Lupus Nephritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066481
Enrollment
Unknown
Registered
2022-12-06
Start date
2022-11-29
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus nephritis

Interventions

Group of patients with lupus nephritis:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with pathological diagnosis of lupus nephritis. 2. The patients signed informed consent and were willing to participate in the study

Exclusion criteria

Exclusion criteria: 1. with other types of nephropathy; 2. The expected survival time is less than 3 years; 3. Complicated with malignant tumor; 4.The patient's informed consent was not obtained

Design outcomes

Primary

MeasureTime frame
Renal function;Liver function;Blood routine;Urine Routine;Urinary albumin/creatinine ratio;—

Countries

CHINA

Contacts

Public ContactZhangxue Hu

West China Hospital of Sichuan University

hzxawy@163.com+86 18980601216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026